CAMBRIDGE, Mass., Jan. 9, 2024 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, announced that on January 8,.
STAT Inhibitors Clinical Trial Analysis: Delveinsight Evaluates A Robust Pipeline As 22+ Influential Pharma Players To Set Foot In The Domain menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
CAMBRIDGE, Mass., Jan. 2, 2024 /PRNewswire/ NeuroBo Pharmaceuticals, Inc. , a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced participation.
NeuroBo Pharmaceuticals, Inc. NRBO shares are trading lower in Friday's premarket session after ending Thursday's session with a whopping 21.2% gain. The…